HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

Médecins Sans Frontières’ concerns over TPP negotiations

As closed-door talks for the Trans-Pacific Partnership (TPP) Agreement resume in Singapore this week, international medical humanitarian organisation Médecins Sans Frontières is calling on Australia and negotiating countries to reject rules that threaten to dismantle internationally agreed public health safeguards and restrict access to medicines in developing countries.

4 Mar 2013

Older patients with head and neck cancers less likely to die in high-volume hospitals

A study of older patients with advanced head and neck cancers has found that where they were treated significantly influenced their survival.

4 Mar 2013

Global Fund launches new funding model, says $1.9B available during transition period

"The Global Fund to Fight AIDS, Tuberculosis and Malaria on Thursday launched a new funding model that allows it to invest more strategically, achieve greater impact, and engage implementers and partners more effectively," a Global Fund press release reports.

2 Mar 2013

GlaxoSmithKline's HIV/AIDS business joins Medicines Patent Pool

"GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine in a patent pool designed to make treatments more widely available in poor countries," Reuters reports.

1 Mar 2013

Macrophages allow entry of HIV in the urethra

Having suggested in 2011 that the urethra is a novel entry site for HIV, a team from the Institut Cochin, has now confirmed this hypothesis and identified the cells and mechanisms brought into play: the immune system cells macrophages, present in the epithelium of the urethra, allow the entry of HIV. This work, published online on the website of the journal Mucosal Immunology, could make it possible to test novel HIV/AIDS prevention strategies.

1 Mar 2013

Patients with diabetes at no increased risk of complications after total knee replacement

Patients with diabetes who undergo total knee replacement surgery do not have increased risk of surgical complications compared to those patients without diabetes, according to a Kaiser Permanente study published today in The Journal of Bone and Joint Surgery.

28 Feb 2013

Post-2015 development agenda should focus on accelerating progress made against HIV, TB, malaria

"In a little more than two years, the world will hit an important target: the date by which the Millennium Development Goals [MDGs] are meant to be achieved," Lucy Chesire, executive director and secretary to the board of the TB ACTION Group, writes in the Huffington Post's "The Big Push" blog.

28 Feb 2013

CSIS report examines Global Health Policy in Second Obama Term

"I am pleased to share with you a new report and video series from the CSIS Global Health Policy Center, 'Global Health Policy in the Second Obama Term,'" J. Stephen Morrison, senior vice president of the Center for Strategic & International Studies (CSIS) and director of the CSIS Global Health Policy Center, writes in a letter posted on the center's "Smart Global Health" blog.

28 Feb 2013

UNAIDS, UNDP release issue brief on TRIPS transition period extensions for LDCs

"The Joint United Nations Programme on HIV/AIDS (UNAIDS) and the United Nations Development Programme (UNDP) today launched a new issue brief", titled "TRIPS transition period extensions for least-developed countries [LDCs]," a UNAIDS press release reports.

28 Feb 2013

Recommendations for PEPFAR to improve data collection, use, distribution

Noting the release of the Institute of Medicine PEPFAR evaluation and an October 2012 report of the Data Working Group of PEPFAR's Scientific Advisory Board, Mead Over and Rachel Silverman of the Center for Global Development propose in the group's "Global Health Policy" blog "four recommendations where there seems to be agreement and feasible opportunities to improve PEPFAR's collection, utilization, and dissemination of data and knowledge."

27 Feb 2013

PEPFAR has helped millions, but 'hard work' lies ahead to sustain gains

PEPFAR, initiated in 2003, is "the largest global health initiative ever undertaken focused on a single disease," a Washington Post editorial writes, noting, "Now, after four years of work, some 400 interviews and visits to 13 nations, the Institute of Medicine of the National Academy of Sciences has provided [an] examination of this incredibly ambitious program."

27 Feb 2013

Examining global efforts against Buruli ulcer

"During my visit to the Médecins Sans Frontières [MSF] Buruli ulcer ward in Cameroon it was wonderful to see the amazing care that the patients receive on a daily basis: antibiotics, state of the art dressings, physiotherapy to help prevent deformities, free food and medicines, and surgery when required," Daniel O'Brien, a specialist adviser with MSF-UK focusing on HIV/AIDS, tuberculosis and Buruli ulcer, writes in the BMJ Group Blogs.

27 Feb 2013

AIDS activists work to influence Kenyan presidential candidates' positions on care, treatment

"A small team of HIV/AIDS activists is trailing Kenyan presidential candidates as they crisscross the country, pressing them to increase their commitment to the care and treatment of people living with HIV," PlusNews reports.

27 Feb 2013

Viewpoints: GOP faces pressure from spending cuts effects on daily life; President needs to lead on Medicare cuts

Cuts this draconian have no place in a tottering economy. But, realistically, the only way to break this standoff is for the cuts to exact their toll on daily life, causing Republicans to face pressure from the public to negotiate an alternative plan with higher revenues in March as part of talks to finance the government for the final six months of the fiscal year.

26 Feb 2013

Complementary medicine risks: an interview with Dr Andrew Boyden, NPS MedicineWise

Complementary medicines include products containing herbs, vitamins, minerals, nutritional supplements, homoeopathic medicines, certain aromatherapy products and traditional Chinese medicines. For this reason they are also called herbal, natural or alternative medicines.

26 Feb 2013

Comprehensive portfolio of antiretroviral products from Mylan

Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary in South Africa, Mylan (Proprietary) Limited, has launched a comprehensive portfolio of antiretroviral (ARV) products.

25 Feb 2013

HIV epidemics and extra-couple relationships: an interview with Steve Bellan, University of Texas

The epicentre of the HIV pandemic is in sub-Saharan Africa, though prevalence of infection varies dramatically between countries for reasons not completely understood.

25 Feb 2013

World closer than ever to ending pediatric AIDS

Writing in the Huffington Post's "Global Motherhood" blog, Chip Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation, highlights the foundation's "first annual 'Global Champions for a Mother's Fight' gala, an opportunity to honor some of our heroes in the battle against pediatric HIV/AIDS and discuss global change, innovation, and advocacy."

24 Feb 2013

Widespread ART coverage can reduce risk of HIV infection, increase life expectancy of general population, studies show

"An intensive campaign to combat HIV/AIDS with costly antiretroviral drugs in rural South Africa has increased life expectancy by more than 11 years and significantly reduced the risk of infection for healthy individuals, according to new research," the Los Angeles Times reports.

23 Feb 2013

USP evaluates Raman device's potential to detect counterfeit and substandard medicines

With substandard and counterfeit medicines a dangerous and growing problem in the developing world and elsewhere, identifying new technologies to detect such drugs is an urgent matter. In a new study published in the Journal of Pharmaceutical and Biomedical Analysis, scientists from the U.S. Pharmacopeial Convention (USP) evaluated a handheld Raman device's potential to detect counterfeit and substandard medicines.

21 Feb 2013

HIV/AIDS News and Research

Further Reading

Médecins Sans Frontières’ concerns over TPP negotiations

Older patients with head and neck cancers less likely to die in high-volume hospitals

Global Fund launches new funding model, says $1.9B available during transition period

GlaxoSmithKline's HIV/AIDS business joins Medicines Patent Pool

Macrophages allow entry of HIV in the urethra

Patients with diabetes at no increased risk of complications after total knee replacement

Post-2015 development agenda should focus on accelerating progress made against HIV, TB, malaria

CSIS report examines Global Health Policy in Second Obama Term

UNAIDS, UNDP release issue brief on TRIPS transition period extensions for LDCs

Recommendations for PEPFAR to improve data collection, use, distribution

PEPFAR has helped millions, but 'hard work' lies ahead to sustain gains

Examining global efforts against Buruli ulcer

AIDS activists work to influence Kenyan presidential candidates' positions on care, treatment

Viewpoints: GOP faces pressure from spending cuts effects on daily life; President needs to lead on Medicare cuts

Complementary medicine risks: an interview with Dr Andrew Boyden, NPS MedicineWise

Comprehensive portfolio of antiretroviral products from Mylan

HIV epidemics and extra-couple relationships: an interview with Steve Bellan, University of Texas

World closer than ever to ending pediatric AIDS

Widespread ART coverage can reduce risk of HIV infection, increase life expectancy of general population, studies show

USP evaluates Raman device's potential to detect counterfeit and substandard medicines

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News